Plexiform Bioscience

Dover, United States

Plexiform Bioscience is the biopharmaceuticals company that develops eye drop formula targeted to treat directly the retina.

$250K raised

Dec 2024

Seed

Biopharma Biotechnology Health Care Medical Wellness

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Plexiform Bioscience

How much funding has Plexiform Bioscience raised?

Plexiform Bioscience has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2024.

Where is Plexiform Bioscience headquartered?

Plexiform Bioscience is headquartered in Dover, United States.

What does Plexiform Bioscience do?

Plexiform Bioscience is the biopharmaceuticals company that develops eye drop formula targeted to treat directly the retina.

What stage is Plexiform Bioscience at?

Plexiform Bioscience is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2024.

MLA

"Plexiform Bioscience — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/plexiform-bioscience. Accessed June 17, 2026.

APA

VCBacked. (2024). Plexiform Bioscience — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/plexiform-bioscience

Wikipedia (cite web)

{{cite web |title=Plexiform Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/plexiform-bioscience |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2024.